期刊文献+

检测脂联素、IGF-1在子宫内膜异位症血清中的水平及与体重指数的相关性研究 被引量:2

Study of Level of Adiponectin ZGF-1 in Endometriosis Serum and Its Relationship with BMI
原文传递
导出
摘要 目的检测子宫内膜异位症血清中脂联素(adiponectin,APN),胰岛素样生长因子-1(IGF-1)的水平及与体重指数(BMI)的相关性。方法应用双抗夹心ELISA法测定40例内膜异位症患者和30例其他妇科良性疾病患者及30例健康体检者的血清APNI,GF-1的水平,并计算所有实验者的BMI。结果内异症患者血清APN水平明显低于对照组(P<0.05)I,GF-1水平高于对照组(P<0.05),内膜异位症患者体重指数低于对照组(P<0.05),而两对照组间无差异(P>0.05)。内膜异位症体重指数与血清脂联素水平呈正相关(r=0.891,P<0.05),而与IGF-1水平呈负相关(r=-0.672,P<0.05)。结论 APNI,GF-1可能参与内膜异位症的发生发展,APN在内膜异位症发展过程中起对抗作用,而IGF-1对内膜异位症维持及发展起促进作用。内膜异位症患者具有较低体重指数,可能是其特有体征之一,其发生机制可能与APNI、GF-1水平变化有关。 Objective To detect the serum level of adiponectin and IGF-1 in endometriosis and inpendence with BMI.Methods Serum level of adiponectin and IGF-1 were measured with ELISA in 40 patients with endometriosis and 60 controlst,herefore compute the BMI of all the experi-ments.Results The level of APN in serum in endometriosis group were significantly lowert,hus IGF-1 were significantly higher than those in the controls(P 〈 0.05),have no difference between the two controls(P 〉 0.05),the BMI of the patients with endometriosis were significantly lower than those of the two controls(P 〈0.05),have no difference between the controls.Conclusion It is likely that APN and IGF-1 may play a role in the pathogenesis of endometriosis,APN withstand the develop of endometriosis,but IGF-1 promote it’s developet,he patients with endometriosis have low BMII,t is a possible particular sign of endometriosis.
作者 蔡大军 马楠
出处 《医药论坛杂志》 2010年第20期28-30,共3页 Journal of Medical Forum
关键词 子宫内膜异位症 脂联素 胰岛素样生长因子-1 酶联免疫吸附法 Endometriosis Adiponectin IGF - 1 Body mass index (BMI) Enzyme linked immunosorbent assay (ELISA)
  • 相关文献

参考文献2

二级参考文献93

  • 1刘军,陈影,刘芳,姚庆姑,许火根,澎名淑,郭瑜琳,陈钦达.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性研究[J].中华内分泌代谢杂志,2004,20(3):215-216. 被引量:30
  • 2何红兵,仲剑平.人脐静脉内皮细胞的长期传代培养[J].第一军医大学学报,1990,10(4):312-315. 被引量:10
  • 3Afita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin act as a platelet-derived growth faetor-BB-binding protein and regulates growth factor-induced eomnmon postreeeptor singaling vascular smooth muscle cell[ J]. Circulation, 2002, 105 (24) : 2893-2898.
  • 4Lusis AJ. Atherosclerosis [ J ]. Nature, 2000, 407 ( 6801 ) : 233- 241.
  • 5Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin [ J]. Circulation, 1999, 100(25) :2473-2476.
  • 6Kobashi C, Urakaze M, Kishida M, et al. Adiponectin inhibits endothelial synthesis of interleukin-8[ J]. Circ Res, 2005,97(12) : 1245-1252.
  • 7Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway [ J]. Circulation, 2000, 102 ( 11 ) : 1296-1301.
  • 8Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway [J]. Diabetes, 2006, 55(6) :1840-1846.
  • 9Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages [ J]. Circulation, 2001, 103 (8) : 1057-1063.
  • 10Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[ J]. Blood, 2000, 96(5) : 1723-1732.

共引文献55

同被引文献12

  • 1郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:278
  • 2CAKMAK H,GUZELOGLU KAYISLI O,KAYISLI U A,et al.Immune-endocrine interactions in endometriosis[J].Front Biosci(Elite Ed),2009,1(1):429-443.
  • 3BUDAK E,FERNNDEZ SNCHEZ M,BELLVER J,et al.Interactions of the hormones leptin,ghrelin,adiponectin,resistin,and PYY3-36 with the reproductive system[J].Fertil Steril,2006,85(6):1563-1581.
  • 4American Society for Reproductive Medicine.Revised American Society for Reproductive Medicine classification of endometriosis:1996[J].Fertil Steril,1997,67(5):817-821.
  • 5KONINCKX P R,BARLOW D,KENNEDY S.Implantation versus infiltration:the Sampson versus the endometriotic disease theory[J].Gynecol Obstet Invest,1999,47(Suppl 1):3-9.
  • 6FILKOV(A) M,HALUZK M,GAY S,et al.The role of resistin as a regulator of inflammation:Implications for various human pathologies[J].Clin Immunol,2009,133(2):157-170.
  • 7BARRIER B F.Immunology of endometriosis[J].Clin Obstet Gynecol,2010,53(2):397-402.
  • 8MATSUZAWA Y.Adiponectin:a key player in obesity related disorders[J].Curr Pharm Des,2010,16(17):1896-1901.
  • 9TAKEMURA Y,OSUGA Y,HARADA M,et al.Concentration of adiponectin in peritoneal fluid is decreased in women with endometriosis[J].Am J Reprod Immunol,2005,54(4):217-221.
  • 10郎景和.子宫内膜异位症基础与临床研究的几个问题[J].中国实用妇科与产科杂志,2002,18(3):129-130. 被引量:301

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部